Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Kathleen A. Cronin, Andrew Lake, Susan Scott, et al.
Cancer (2018) Vol. 124, Iss. 13, pp. 2785-2800
Open Access | Times Cited: 1360

Showing 1-25 of 1360 citing articles:

Cancer statistics, 2019
Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal
CA A Cancer Journal for Clinicians (2019) Vol. 69, Iss. 1, pp. 7-34
Open Access | Times Cited: 18940
Cancer Statistics, 2021
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs, et al.
CA A Cancer Journal for Clinicians (2021) Vol. 71, Iss. 1, pp. 7-33
Open Access | Times Cited: 14826
Lung Cancer 2020
Brett C. Bade, Charles S. Dela Cruz
Clinics in Chest Medicine (2020) Vol. 41, Iss. 1, pp. 1-24
Closed Access | Times Cited: 1474
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention
Daniel Q. Huang, Hashem B. El–Serag, Rohit Loomba
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 4, pp. 223-238
Open Access | Times Cited: 1371
Annual report to the nation on the status of cancer, part I: National cancer statistics
S. Jane Henley, Elizabeth Ward, Susan Scott, et al.
Cancer (2020) Vol. 126, Iss. 10, pp. 2225-2249
Open Access | Times Cited: 767
Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects
Simin Tang, Xueting Deng, Jian Zhou, et al.
Biomedicine & Pharmacotherapy (2019) Vol. 121, pp. 109604-109604
Open Access | Times Cited: 510
Ovarian damage from chemotherapy and current approaches to its protection
Norah Spears, Federica Lopes, Agnes Stefansdottir, et al.
Human Reproduction Update (2019) Vol. 25, Iss. 6, pp. 673-693
Open Access | Times Cited: 490
Medical Care Costs Associated with Cancer Survivorship in the United States
Angela B. Mariotto, Lindsey Enewold, Jingxuan Zhao, et al.
Cancer Epidemiology Biomarkers & Prevention (2020) Vol. 29, Iss. 7, pp. 1304-1312
Open Access | Times Cited: 472
Cancer Statistics for Hispanics/Latinos, 2018
Kimberly D. Miller, Ann Goding Sauer, Ana P. Ortíz, et al.
CA A Cancer Journal for Clinicians (2018) Vol. 68, Iss. 6, pp. 425-445
Open Access | Times Cited: 431
Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017
David A. Siegel, Mary Elizabeth O’Neil, Thomas B. Richards, et al.
MMWR Morbidity and Mortality Weekly Report (2020) Vol. 69, Iss. 41, pp. 1473-1480
Open Access | Times Cited: 414
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics
Farhad Islami, Elizabeth Ward, Hyuna Sung, et al.
JNCI Journal of the National Cancer Institute (2021) Vol. 113, Iss. 12, pp. 1648-1669
Open Access | Times Cited: 381
Endometrial cancer
Vicky Makker, Helen Mackay, Isabelle Ray‐Coquard, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 374
Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to Its Deficiency
Diana Fiorentini, Concettina Cappadone, Giovanna Farruggia, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1136-1136
Open Access | Times Cited: 347
Projected estimates of cancer in Canada in 2020
Darren R. Brenner, Hannah K. Weir, Alain Demers, et al.
Canadian Medical Association Journal (2020) Vol. 192, Iss. 9, pp. E199-E205
Open Access | Times Cited: 340
Machine learning approaches to drug response prediction: challenges and recent progress
George Alexandru Adam, Ladislav Rampášek, Zhaleh Safikhani, et al.
npj Precision Oncology (2020) Vol. 4, Iss. 1
Open Access | Times Cited: 332
Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20–49 Years
Elizabeth Ward, Recinda Sherman, S. Jane Henley, et al.
JNCI Journal of the National Cancer Institute (2019) Vol. 111, Iss. 12, pp. 1279-1297
Open Access | Times Cited: 278
Analysis of status and countermeasures of cancer incidence and mortality in China
Chunchun Wu, Mengna Li, Hanbing Meng, et al.
Science China Life Sciences (2019) Vol. 62, Iss. 5, pp. 640-647
Open Access | Times Cited: 264
Epidemiology and risk-stratification of NAFLD-associated HCC
George N. Ioannou
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1476-1484
Open Access | Times Cited: 260
Automatic multiorgan segmentation in thorax CT images using U‐net‐GAN
Xue Dong, Yang Lei, Tonghe Wang, et al.
Medical Physics (2019) Vol. 46, Iss. 5, pp. 2157-2168
Open Access | Times Cited: 253
Colon Cancer: A Clinician’s Perspective in 2019
Monjur Ahmed∥
Gastroenterology Research (2020) Vol. 13, Iss. 1, pp. 1-10
Open Access | Times Cited: 228
Progress in cancer mortality, incidence, and survival: a global overview
Claudia Santucci, Greta Carioli, Paola Bertuccio, et al.
European Journal of Cancer Prevention (2020) Vol. 29, Iss. 5, pp. 367-381
Closed Access | Times Cited: 224
Design and Challenges of Sonodynamic Therapy System for Cancer Theranostics: From Equipment to Sensitizers
Zhuoran Gong, Zhifei Dai
Advanced Science (2021) Vol. 8, Iss. 10
Open Access | Times Cited: 220
Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics
Serban Negoita, Eric J. Feuer, Angela B. Mariotto, et al.
Cancer (2018) Vol. 124, Iss. 13, pp. 2801-2814
Open Access | Times Cited: 218
Immunotherapy for hepatocellular carcinoma
Zongyi Yin, Xiaowu Li
Cancer Letters (2019) Vol. 470, pp. 8-17
Closed Access | Times Cited: 218
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
Robert E. Coleman, Dianne M. Finkelstein, Carlos H. Barrios, et al.
The Lancet Oncology (2019) Vol. 21, Iss. 1, pp. 60-72
Closed Access | Times Cited: 217
Page 1 - Next Page

Scroll to top